Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
about
Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants.Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.Ciclosporin aerosol in lung transplantation.Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.Loss of basal cells precedes bronchiolitis obliterans-like pathological changes in a murine model of chlorine gas inhalation.Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside.Constrictive bronchiolitis obliterans: the fibrotic airway disorder.The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.Analysis of plasma surfactant protein D levels in lung transplant recipients.Prevention of chronic rejection after lung transplantation.Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus
P2860
Q28743093-7F546AF7-6222-4D0B-992C-7DB59D34BBADQ33236000-7F578AD8-7661-463F-977D-204CB5FAABA8Q34533624-653DF843-3F4A-4890-A734-F3080FA21985Q35669011-6259E1B2-395E-456D-A569-8FBEBED77870Q36543083-1041F7E6-AF16-4E28-9C7A-ECE505C80B98Q36623201-2E7743DC-E954-407C-B824-0A1B219DFED2Q37122569-8BFAAF70-B93A-4D03-95BB-C37DC3803840Q37596424-2B66EF71-1F09-4531-AF55-A11A2CA5BEBEQ38057375-50826856-3151-4D93-A0AD-38848CFFAA61Q40188612-7F4381C1-E0B5-46FA-83D9-BEBE7CF717DDQ41657586-50480E42-36B3-4B41-9A1B-F3A4FAAC58F1Q42270252-71067421-AACF-4F25-AF91-8703754EF751Q47662940-E994CDD6-2148-4010-A393-97A35DC452E3Q58796793-DFA4B926-FED8-4DE9-AE9E-C5465855B66F
P2860
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@ast
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@en
type
label
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@ast
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@en
prefLabel
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@ast
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@en
P2093
P1433
P1476
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.
@en
P2093
Andrew I R Scott
Linda D Sharples
Susan Stewart
P304
P356
10.2165/00003495-200565060-00004
P577
2005-01-01T00:00:00Z
P6179
1038300761